CN103893670B - 一种治疗心脑血管病的中药药丸 - Google Patents
一种治疗心脑血管病的中药药丸 Download PDFInfo
- Publication number
- CN103893670B CN103893670B CN201210571128.4A CN201210571128A CN103893670B CN 103893670 B CN103893670 B CN 103893670B CN 201210571128 A CN201210571128 A CN 201210571128A CN 103893670 B CN103893670 B CN 103893670B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- traditional chinese
- chinese medicine
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000026106 cerebrovascular disease Diseases 0.000 title claims abstract description 22
- 239000006187 pill Substances 0.000 title claims abstract description 16
- 239000003814 drug Substances 0.000 title claims abstract description 11
- 210000000582 semen Anatomy 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 239000009636 Huang Qi Substances 0.000 claims abstract description 6
- 241000242759 Actiniaria Species 0.000 claims abstract description 5
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 5
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 17
- 230000002526 effect on cardiovascular system Effects 0.000 claims description 15
- 241000628997 Flos Species 0.000 claims description 4
- 241000237636 Pheretima Species 0.000 claims description 4
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 4
- 240000006079 Schisandra chinensis Species 0.000 claims description 4
- 241000222336 Ganoderma Species 0.000 claims 1
- 241000222481 Schizophyllum commune Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 5
- 235000008434 ginseng Nutrition 0.000 abstract description 5
- 240000008397 Ganoderma lucidum Species 0.000 abstract description 4
- 235000001637 Ganoderma lucidum Nutrition 0.000 abstract description 4
- 239000000203 mixture Substances 0.000 abstract description 3
- 240000001341 Reynoutria japonica Species 0.000 abstract 2
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 241000304531 Allium macrostemon Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 241000243684 Lumbricus Species 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 240000004371 Panax ginseng Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 28
- 210000004369 blood Anatomy 0.000 description 28
- 210000004185 liver Anatomy 0.000 description 24
- 210000002216 heart Anatomy 0.000 description 22
- 230000006870 function Effects 0.000 description 21
- 208000002193 Pain Diseases 0.000 description 20
- 210000004072 lung Anatomy 0.000 description 20
- 230000036407 pain Effects 0.000 description 20
- 210000000952 spleen Anatomy 0.000 description 17
- 235000009508 confectionery Nutrition 0.000 description 15
- 201000010099 disease Diseases 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 210000003734 kidney Anatomy 0.000 description 15
- 238000011282 treatment Methods 0.000 description 15
- 230000001737 promoting effect Effects 0.000 description 13
- 210000002784 stomach Anatomy 0.000 description 13
- 208000024891 symptom Diseases 0.000 description 13
- 206010011224 Cough Diseases 0.000 description 11
- 206010062717 Increased upper airway secretion Diseases 0.000 description 9
- 210000001015 abdomen Anatomy 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 9
- 208000001848 dysentery Diseases 0.000 description 9
- 208000026435 phlegm Diseases 0.000 description 9
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 208000002173 dizziness Diseases 0.000 description 8
- 206010022437 insomnia Diseases 0.000 description 8
- 208000006820 Arthralgia Diseases 0.000 description 7
- 206010033557 Palpitations Diseases 0.000 description 7
- 210000000038 chest Anatomy 0.000 description 7
- 201000000736 Amenorrhea Diseases 0.000 description 6
- 206010001928 Amenorrhoea Diseases 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 231100000540 amenorrhea Toxicity 0.000 description 6
- 208000006673 asthma Diseases 0.000 description 6
- 210000005036 nerve Anatomy 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 208000008454 Hyperhidrosis Diseases 0.000 description 5
- 206010047700 Vomiting Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 230000001914 calming effect Effects 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 241000208340 Araliaceae Species 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 230000002490 cerebral effect Effects 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 201000006549 dyspepsia Diseases 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 235000019615 sensations Nutrition 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010019468 Hemiplegia Diseases 0.000 description 3
- 206010021118 Hypotonia Diseases 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 208000003443 Unconsciousness Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 208000017561 flaccidity Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 230000004206 stomach function Effects 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 206010006895 Cachexia Diseases 0.000 description 2
- 208000031868 Calculus ureteric Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010011703 Cyanosis Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 241000218989 Trichosanthes Species 0.000 description 2
- 208000000014 Ureteral Calculi Diseases 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000002567 autonomic effect Effects 0.000 description 2
- 239000007766 cera flava Substances 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 208000026500 emaciation Diseases 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 208000000884 Airway Obstruction Diseases 0.000 description 1
- 206010059245 Angiopathy Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 241000195622 Astasia Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 206010008088 Cerebral artery embolism Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000000386 Hypertensive Intracranial Hemorrhage Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 201000002481 Myositis Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010040026 Sensory disturbance Diseases 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010063900 Steal syndrome Diseases 0.000 description 1
- 208000032851 Subarachnoid Hemorrhage Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000032109 Transient ischaemic attack Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 208000006218 bradycardia Diseases 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000003130 cardiopathic effect Effects 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 231100000880 dysequilibrium Toxicity 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- -1 hyperchromia Substances 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 201000009939 hypertensive encephalopathy Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 201000010849 intracranial embolism Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 201000003144 pneumothorax Diseases 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 230000009863 secondary prevention Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000000779 thoracic wall Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 201000010875 transient cerebral ischemia Diseases 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗心脑血管病的中药药丸,由以下重量份数的中药为原料制成:黄芪20、裂褶菌7、丹参20、当归10、白芍4、制首乌10、炒枣仁10、柏子仁4、远志4、九节菖蒲4、苦参5、红花5、地龙5、葛根10、砂仁2、薤白2、瓜蒌皮4、莪术4、茯苓5、麦冬5、北五味2、郁金5、山楂5、合欢皮和刺五加皮4、狗脊10、首乌藤10、桂枝2、陈皮2、炙甘草4、灵芝2、枸杞子10、玉竹10。本发明以天然的中药材为原料,各味中药药效间具有协同作用,疗效显著,能有效治疗乳腺增生疾病,本发明制成药丸服用,服用方便,且对身体无毒副作用。
Description
技术领域
本发明涉及一种治疗心脑血管病的中药药丸,属于中药领域。
背景技术
心脑血管疾病是心血管疾病和脑血管疾病的统称,泛指由于高脂血症、血液黏稠、动脉粥样硬化、高血压等所导致的心脏、大脑及全身组织发生缺血性或出血性疾病的通称。
心血管疾病,又称为循环系统疾病,是一系列涉及循环系统的疾病,循环系统指人体内运送血液的器官和组织,主要包括心脏、血管(动脉、静脉、微血管),可以细分为急性和慢性,一般都是与动脉硬化有关。心脑血管疾病是一种严重威胁人类,特别是50岁以上中老年人健康的常见病,即使应用目前最先进、 完善的治疗手段,仍可有50%以上的脑血管意外幸存者生活不能完全自理!全世界每年死于心脑血管疾病的人数高达1500万人,居各种死因首位。心脑血管疾病已成为人类死亡病因最高的头号杀手,也是人们健康的“无声凶煞”!
心脑血管疾病具有“发病率高、致残率高、死亡率高、复发率高,并发症多” 即“四高一多”的特点,目前,我国心脑血管疾病患者已经超过2.7亿人!我国每年死于心脑血管疾病近300万人,占我国每年总死亡病因的51%。而幸存下来的患者75%不同程度丧失劳动能力,40%重残!我国脑中风病人出院后第一年的复发率是30%,第五年的复发率高达59%,而二级预防做得较好的美国仅为10%。由于我国医疗保险覆盖人群小,脑中风病人的复发率与国际平均水平相比要高出1倍!
发明内容
本发明目的是提供一种能够治疗心脑血管病的中药药丸,该药丸以纯天然中药为原料,疗效显著且无毒副作用。
本发明的方案如下:一种治疗心脑血管病的中药药丸,由以下重量份数的中药为原料制成:黄芪20、白参7、丹参20、当归10、白芍4、制首乌10、炒枣仁10、柏子仁4、远志4、九节菖蒲4、川参5、红花5、地龙5、葛根10、砂仁2、薤白2、栝楼皮4、莪术4、茯苓5、麦冬5、北五味2、郁金5、山楂5、合欢皮和刺五加皮4、狗脊10、夜交藤10、桂枝2、陈皮2、炙甘草4、木灵芝2、枸杞子10、玉竹10。
可以将上述药物制成药剂学上的任何一种口服剂型,如胶囊剂、散剂、片剂、丸剂,本发明优先的剂型是丸剂。
制备方法:称取上述重量份原料,混合,烘干,粉碎成80-120目细粉,加入与药粉重量比为1:1的炼蜜,混合均匀,制条,以5克/丸成丸,蜂蜡封存即可。
服用方法:口服,每日早中晚饭后一小时服用,每次二丸,用白开水送服。重症患者于晚睡前再加服二丸。3个月为一疗程,一般需要2-3个疗程。
各味中药药理作用:
黄芪:黄芪:性温,味甘。补气固表,托毒排脓,利尿,生肌。用于气虚乏力、久泻脱肛、自汗、水肿、子官脱垂、慢性肾炎蛋白尿、糖尿病、疮口久不愈合。
白参:性平,味甘,气味(根)苦、微寒、无毒。白参含有裂招菌多糖具有抗癌作用。具滋补强身的功效。气味(根)苦、微寒、无毒。有清肝明目、滋补强身的功效,特别对小儿盗汗、妇科疾病、神经衰弱、头昏耳鸣等症疗效明显。”丹参
当归:甘辛,温。入心、肝、脾经。补血和血,调经止痛,润燥滑肠。治月经不调,经闭腹痛,癥瘕结聚,崩漏;血虚头痛,眩晕,痿痹;肠燥便难,赤痢后重;痈疽疮窃,跌扑损伤。
白芍:苦酸,凉。入肝、脾经。养血柔肝,缓中止痛,敛阴收汗。治胸腹胁肋疼痛,泻痢腹痛,自汗盗汗,阴虚发热,月经不调,崩漏,带下。
制首乌:味苦、甘、涩,性温平。补益精血,养肝安神,强筋骨,固肾乌须,用于血虚而见头昏目眩,心悸失眠健忘,萎黄乏力,肝肾精血亏虚的眩晕耳鸣,腰膝酸软,遗精崩带,须发早白等症。
枣仁:甘,平。入心、脾、肝、胆经。主治养肝,宁心,安神,敛汗。治虚烦不眠,惊悸怔忡,烦渴,虚汗。
柏子仁:甘,平。归心、肾、大肠经。功能主治:养心安神,润肠通便。用于虚烦不眠,心悸怔忡,肠燥便秘等症。
远志:苦、辛,微温。归心、肾、肺经。功能主治:安神益智,祛痰,消肿。用于心肾不交引起的失眠多梦,健忘惊悸,神志恍惚,咳嗽痰多,疮疡肿毒,乳房肿痛。
九节菖蒲:辛;温 。归经:心;肝;脾经 。功能主治:化痰开窍;安神;宣湿醒脾;解毒。主热病神昏;癫痫;气闭耳聋;多梦健忘;胸闷腹胀;食欲不振;风湿痹痛;痈疽;疥癣。
川参:味苦,性寒;归肝,肾,大肠,小肠经,膀胱,心经。功效与作用:清热燥湿;祛风杀虫。主治湿热泻痢;肠风便血;黄疸;小便不利;水肿;带下;阴痒;疥癣;麻风;皮肤瘙痒;湿毒疮疡。
红花:性温,味辛。入心、肝经。功能主治:活血通经,散淤止痛,用于闭经,痛经,恶露不行,症瘕痞块,跌扑损伤,疮疡肿痛。
地龙:功能主治,热病惊狂、小儿惊风、咳喘、头痛目赤、咽喉肿痛、小便不通、风湿关节疼痛,半身不遂 等症。外用涂丹毒、漆疮等症。1.清热息风:主治壮热惊痫,动风抽搐。2.清肺定喘:可治肺热痰咳气喘,对肺热型支气管哮喘疗效较好。3.利尿通淋:适用于湿热下注,热淋涩痛。4.通行经络:可用治热痹节肿赤痛;适当配伍也可治寒痹;配伍益气行血药常用于气虚血瘀,经络不利,偏瘫失语者。
葛根:甘辛,平。入脾、胃经。功用主治:升阳解肌,透疹止泻,除烦止温。治伤寒、温热头痛项强,烦热消渴,泄泻,痢疾,癍疹不透,高血压,心绞痛,耳聋。
砂仁:辛,温。入脾、胃经。功用主治:行气调中,和胃,醒脾。治腹痛痞胀,胃呆食滞,噎膈呕吐,寒泻冷痢,妊娠胎动。
薤白:辛苦,温。入足厥阴肝经、手太阴肺经、手少阴心经。功用主治:理气,宽胸,通阳,散结。治胸痹心痛彻背,脘痞不舒,干呕,泻痢后重,疮疖。
莪术:苦辛,温。入肝、脾经。功能主治: 破血行气,消积止痛。用于血瘀腹痛、肝脾肿大、心腹胀痛,积聚,妇女血瘀经闭,跌打损伤作痛饮食积滞。(1)行气止痛,破血消积:用于气滞血瘀之经闭、胸胁痛、腹痛及症瘕肿块等。常配三棱。(2)消食化积:用于饮食积滞之胃腹胀痛,常配焦麦芽、焦槟榔。
茯苓:甘淡,平。入心、脾、肺经。渗湿利水,益脾和胃,宁心安神。治小便不利,水肿胀满,痰饮咳逆,呕哕,泄泻,遗精,淋浊,惊悸,健忘。
麦冬:甘,微苦,微寒。归心、肺、胃经。养阴生津,润肺清心。用于肺燥干咳,虚痨咳嗽,津伤口渴,心烦失眠,内热消渴,肠燥便秘,咽白喉。
北五味:酸,温。入肺、肾经。功用主治:敛肺,滋肾,生津,收汗,涩精。治肺虚喘咳,口干作渴,自汗,盗汗,劳伤羸瘦,梦遗滑精,久泻久痢。
郁金:辛苦,凉。入心、肺、肝经。功用主治:行气解郁,凉血破瘀。治胸腹胁肋诸痛,失心癫狂,热病神昏,吐血,衄血,尿血,血淋,妇女倒经,黄疸。
山楂:酸甘,微温。入脾、胃、肝经。功用主治:消食积,散瘀血,驱绦虫。治肉积,癥瘕,痰饮,痞满,吞酸,泻痢,肠风,腰痛,疝气产后儿枕痛,恶露不尽,小儿乳食停滞。消食健胃,行气散瘀。用于肉食积滞、胃烷胀满、泻痢腹痛、瘀血经闭、产后瘀阻、心腹刺痛、疝气疼痛、高血脂症。
合欢皮:甘,平。入心、肝经。功用主治:解郁,和血,宁心,消痈肿。治心神不安,忧郁失眠,肺痈,痈肿,瘰疬,筋骨折伤。
刺五加皮:为刺五加的皮,味辛;苦;微甘;性温。归肝经;肾经。主治:风寒湿痹;腰膝疼痛;筋骨痿软;行动迟缓;体虚羸弱;跌打损伤;骨折;水肿;脚气;阴下湿痒。
狗脊:苦甘,温。入肝、肾经。功用主治:补肝肾,除风湿,健腰脚,利关节。治腰背酸疼,膝痛脚弱,寒湿周痹,失溺,尿频,遗精,白带。
夜交藤:甘微苦,平。入心、肝经。功用主治:养心,安神,通络,祛风。治失眠,劳伤,多汗,血虚身痛,痈疽,瘰疬,风疮疥癣。
桂枝:辛甘,温。入膀胱、心、肺经。功用主治:发汗解肌,温经通脉。治风寒表证,肩背肢节酸疼,胸痹痰饮,经闭癥瘕。
陈皮:性温,味辛、味苦。 归入脾经、胃经、肺经。主治功效:理气健脾,调中,燥湿,化痰。主治 脾胃气滞之脘腹胀满或疼痛、消化不良。湿浊阻中之胸闷腹胀、纳呆便溏。痰湿壅肺之咳嗽气喘。用于胸脘胀满,食少吐泻,咳嗽痰多。
炙甘草:甘,平。归心、肺、脾、胃经 。功能与主治:补脾和胃,益气复脉。用于脾胃虚弱,倦怠乏力,心动悸,脉结代,可解附子毒。
木灵芝:甘,平。归心、肝、脾、肺、肾五经。主治虚劳、咳嗽、气喘、失眠、消化不良,恶性肿瘤等。
枸杞子:味甘;性平。归肝经;肾经;肺经。功能:养肝;滋肾;润肺。主治:肝肾亏虚;头晕目眩;目视不清;腰膝酸软;阳痿遗精;虚劳咳嗽;消渴引饮。
玉竹:味甘,性平。归肺;胃经。功效主治:滋阴润肺;养胃生津。燥咳;劳嗽;热病阴液耗伤之咽干口渴;内热消渴;阴虚外感;头昏眩晕;筋脉挛痛。
本发明以天然的中药材为原料,各味中药药效间具有协同作用,补心气、养心阴、湿心阳、安心神、活血化瘀、通络止痛,主治心脑血管病、心律不齐、心肌缺血、心血瘀阴、动脉硬化、脑血管栓塞、半身不遂等症,本发明制成药丸,服用方便,且对身体无毒副作用。
下面结合临床试验数据来说明本发明的有益效果:
1、自2009年3月至2011年10月,本发明人应用本发明所制药丸观察治疗200例心脑血管患者。其中:心血管病患者112例,年龄最大者74岁,年龄最小者43岁,男性65人,女性57人;脑血管病患者88例,年龄最大者79岁,年龄最小者41岁,男性50人,女性38人。
2、诊断标准:
A、心血管病
心悸,主观感觉及客观征象的综合症状心血管疾病。主观上患者感觉心脏跳动快速、不整或搏动有力。客观检查可见心跳频率过快、过缓或不齐,即有心率和心律的变化。
呼吸困难,是主观感觉和客观征象的综合表现。主观上感觉呼吸费力,客观上呼吸次数增多,动作快而幅度加大。胸部的各种器官都可以出现呼吸困难的症状。如脑梗塞,肺炎,急性气胸,气道堵塞,胸壁肌肉炎症,肋骨骨折等,甚至皮肤带状疱疹的疾病疼痛也可以导致呼吸困难。心脏病心脏病的呼吸困难多为渐进性,逐步加重。
紫绀,指粘膜和皮肤呈青紫色。体内还原血红蛋白(未经氧饱和的血红蛋白)绝对值超过5g%。紫绀的机制为缺氧血,血红蛋白过多,及血液淤滞。有中心型及周边型两种。
眩晕,是临床上常见的症状,是人体对于空间关系的定向感觉障碍或平衡感觉障碍,使患者自觉周围景物或自身在旋转及摇晃,眩晕发作时常伴有平衡失调、站立不稳及恶心、呕吐、面色苍白出汗、心动过缓、血压下降等植物神经功能紊乱症状。
晕厥,是由于一时性广泛的脑缺血、缺氧,引起突然的、可逆的、短暂的意识丧失的一种临床病征。在发生意识丧失前常伴有面色苍白、恶心、呕吐、头晕、出汗等植物神经功能紊乱现象。
疲劳,是各种心脏病常有的症状。当心脏病使血液循环不畅,新陈代谢废物(主要是乳酸)即可积聚在组织内,刺激神经末稍,令人产生疲劳感。
B、脑血管病:急性脑血管病包括短暂性脑缺血发作、脑血栓形成、脑栓塞、高血压脑病、脑出血和蛛网膜下腔出血等;慢性脑血管病包括脑动脉硬化、脑血管病性痴呆、脑动脉盗血综合征、帕金森氏病等。
3、治疗方法:口服,每日早中晚饭后一小时服用,每次二丸,用白开水送服。重症患者于晚睡前再加服二丸,3个月为一疗程。
4、疗效标准:
治愈:经过2-3个疗程后,各症状及临床体征消失,其他客观检查指标基本正常;
显效:经过2-3个疗程后,各症状及临床体征减轻,其他客观检查指标明显改善;
无效:经过2-3个疗程后,各症状及临床体征无改善或加重,其他客观检查指标改善或加重。
5、治疗结果:对心血管病患者112例进行治疗观察,98例患者取得治愈效果,10例串者显效效果,4例患者治疗无效;对脑血管病患者88例进行治疗观察,75例患者取得治愈效果,8例患者显效效果,5例患者治疗无效;总治愈率86%,总显效率9%,总无效率5%。
具体实施方式
为了更好的理解和实施本发明,下面结合具体实施例进一步说明本发明。
实施例
称取黄芪20、白参7、丹参20、当归10、白芍4、制首乌10、炒枣仁10、柏子仁4、远志4、九节菖蒲4、川参5、红花5、地龙5、葛根10、砂仁2、薤白2、栝楼皮4、莪术4、茯苓5、麦冬5、北五味2、郁金5、山楂5、合欢皮和刺五加皮4、狗脊10、夜交藤10、桂枝2、陈皮2、炙甘草4、木灵芝2、枸杞子10、玉竹10。
制备方法:称取上述实施例按所需重量份原料,混合,烘干,粉碎成80-120目细粉,加入与药粉重量比为1:1的炼蜜,混合均匀,制条,以5克/丸成丸,蜂蜡封存即可。
服用方法:口服,每日早中晚饭后一小时服用,每次二丸,用白开水送服。重症患者于晚睡前再加服二丸。3个月为一疗程,一般需要2-3个疗程。
尽管上文对本发明的具体实施方式给予了详细描述和说明,但是应该指明的是,我们可以依据本发明的构想对上述实施方式进行各种等效改变和修改,其所产生的功能作用仍未超出说明书所涵盖的精神时,均应在本发明的保护范围之内。
Claims (1)
1.一种治疗心脑血管病的中药药丸,其特征是,由以下重量份数的中药为原料制成:黄芪20、裂褶菌7、丹参20、当归10、白芍4、制首乌10、炒枣仁10、柏子仁4、远志4、九节菖蒲4、苦参5、红花5、地龙5、葛根10、砂仁2、薤白2、瓜蒌皮4、莪术4、茯苓5、麦冬5、北五味2、郁金5、山楂5、合欢皮和刺五加皮4、狗脊10、首乌藤10、桂枝2、陈皮2、炙甘草4、灵芝2、枸杞子10、玉竹10。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210571128.4A CN103893670B (zh) | 2012-12-26 | 2012-12-26 | 一种治疗心脑血管病的中药药丸 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210571128.4A CN103893670B (zh) | 2012-12-26 | 2012-12-26 | 一种治疗心脑血管病的中药药丸 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103893670A CN103893670A (zh) | 2014-07-02 |
CN103893670B true CN103893670B (zh) | 2015-04-08 |
Family
ID=50985454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210571128.4A Active CN103893670B (zh) | 2012-12-26 | 2012-12-26 | 一种治疗心脑血管病的中药药丸 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103893670B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106237262A (zh) * | 2016-09-18 | 2016-12-21 | 黄继明 | 一种中药保心丸 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105477380A (zh) * | 2015-12-16 | 2016-04-13 | 牛鸿祥 | 一种治疗心脑血管疾病的中药及其制备方法 |
CN108837120A (zh) * | 2018-07-28 | 2018-11-20 | 兰永贤 | 一种治心脑血管疾病的中药丸剂 |
CN112076264A (zh) * | 2020-09-02 | 2020-12-15 | 秦进 | 一种辅助治疗脑梗及脑梗后遗症的中药制剂及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101020028B (zh) * | 2006-11-11 | 2010-05-19 | 刘光辉 | 一种治疗心脑血管疾病的中药 |
-
2012
- 2012-12-26 CN CN201210571128.4A patent/CN103893670B/zh active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106237262A (zh) * | 2016-09-18 | 2016-12-21 | 黄继明 | 一种中药保心丸 |
Also Published As
Publication number | Publication date |
---|---|
CN103893670A (zh) | 2014-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103432390B (zh) | 一种治疗冠心病的药物及其制备方法 | |
CN103893670B (zh) | 一种治疗心脑血管病的中药药丸 | |
CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
CN104873705A (zh) | 一种治疗冠心病心绞痛的药物组合物及其应用 | |
CN104399009A (zh) | 治疗肝癌的中药配方及其制备方法 | |
CN105535390A (zh) | 一种治疗冠心病的中药汤剂及其制备方法 | |
CN105168460A (zh) | 治疗原发性三叉神经痛的制剂 | |
CN103919910A (zh) | 一种治疗冠心病的药物 | |
CN102614462B (zh) | 治疗冠心病的中药组合物及其制备方法 | |
CN105232987A (zh) | 一种促进神经外科术后康复的中药 | |
CN104906507A (zh) | 一种降低血压、调理体质的中药组合物 | |
CN103860773A (zh) | 用于治疗心肌缺血的中药组合物及其制备方法 | |
CN103285328B (zh) | 治疗冠心病的中药组合物胶囊的制备方法 | |
CN105435131A (zh) | 一种治疗慢性心衰的中药组合物及其制备方法 | |
CN104958677A (zh) | 一种治疗膜性肾病的中药制剂及其制备方法 | |
CN104800610A (zh) | 一种治疗帕金森病的中药制剂及其制备方法 | |
CN105727163A (zh) | 一种治疗肝癌的中药配方及其制备方法 | |
CN104338052A (zh) | 治疗脑血栓的中药配方 | |
CN103330911B (zh) | 治疗冠心病的中药组合物粉剂及其制备方法 | |
CN105687962A (zh) | 治疗冠状动脉粥样硬化的冲剂及制备方法 | |
CN103285327B (zh) | 治疗冠心病的中药组合物片剂及其制备方法 | |
CN104436060A (zh) | 一种护理治疗胆管细胞癌的中药配方及其制备方法 | |
CN105748911A (zh) | 术后肿瘤患者抗副反应胶囊剂的制备方法 | |
CN104587190A (zh) | 一种治疗心绞痛的中药 | |
CN104524535A (zh) | 一种治疗慢性肺源性心脏病的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240523 Address after: No. 98 Qicang Road, Mingguang City, Chuzhou City, Anhui Province, 239000 Patentee after: Mingguang Jiuzhi Intellectual Property Management Co.,Ltd. Country or region after: China Address before: No. 224-6, Chihe Avenue, Mingguang City, Anhui Province, 239441 Patentee before: Liu Yaoshi Country or region before: China |